ABO非同型血小板输注的现状及建议*

doi:10.3969/j.issn.1671-2587.2024.01.003

临床输血与检验 ›› 2024, Vol. 26 ›› Issue (1): 17-22.DOI: 10.3969/j.issn.1671-2587.2024.01.003

ABO非同型血小板输注的现状及建议^*

阳雪新, 魏亚明

广州市第一人民医院输血医学科,广东广州 510180

收稿日期:2023-12-11 发布日期:2024-03-13
通讯作者: 魏亚明,主要从事输血免疫及细胞治疗等方面研究,（E-mail）weiyaming@163.com。
作者简介:阳雪新,主要从事输血免疫学方面研究,（E-mail）904061339@qq.com。
基金资助:
*本研究受广东省企联合面上项目（No.2021A1515220044）、广州市临床重大技术项目（No.2019ZD18）资助

The Current Situation and Suggestions of ABO-mismatched Platelet Transfusions

YANG Xuexin, WEI Yaming

Department of Blood Transfusion, Guangzhou First People's Hospital, Guangzhou, Guangdong 510180

Received:2023-12-11 Published:2024-03-13

摘要/Abstract

摘要： ABO非同型血小板输注在国外已广泛应用。近年来,国内也已有了地方性应用专家共识,但由于相关专业知识的不普及,使得临床普遍担心ABO非同型血小板输注的安全性和有效性,导致国内ABO非同型血小板应用较少,特别是紧急抢救没有同型血小板时也不使用。本文介绍了ABO非同型血小板输注的概念、血小板上的红细胞血型抗原及国内血小板供需现状,阐述了国内外ABO非同型血小板输注在安全性和有效性方面的研究进展,总结提出了ABO非同型血小板输注的指导建议,为ABO非同型血小板国内临床输注提供应用策略。

关键词: ABO血型, ABO血型不合, 血小板输注, 安全性, 有效性

Abstract: ABO-mismatched platelet transfusions have been widely used developed country. In recent years, there has been expert consensus on local application in China, but due to the lack of professional knowledge, the safety and effectiveness of ABO-mismatched platelet transfusion are generally concerned, resulting in less application of ABO mismatched platelets in China, even in emergency cases. This paper introduced the concept of ABO mismatched platelet transfusions、red blood cell antigen on platelet、platelet supply imbalance and demand, summarized the research progress of ABO mismatched platelet transfusions in safety and efficacy, suggested the guidance of ABO mismatched platelet transfusions to provide application strategies for clinical transfusion.

Key words: ABO blood group, ABO-mismatched, Platelet transfusion, Safety, Effectiveness

中图分类号:

R457

阳雪新, 魏亚明. ABO非同型血小板输注的现状及建议^*[J]. 临床输血与检验, 2024, 26(1): 17-22.

YANG Xuexin, WEI Yaming. The Current Situation and Suggestions of ABO-mismatched Platelet Transfusions[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(1): 17-22.

参考文献

[1] BOUGIE D W,REESE S E,BIRCH R J,et al.Associations between ABO non-identical platelet transfusions and patient outcomes-a multicenter retrospective analysis[J].Transfusion,2023,63(5):960-972.
[2] ZULKEFLEE R H,HASSAN M N,HASSAN R,et al.Acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion:two case reports[J].Transfus Apher Sci,2023,62(3):103658.
[3] 异基因造血干细胞移植临床输血专家共识起草专案组.异基因造血干细胞移植临床输血专家共识[J].临床输血与检验,2023,25(5):586-593.
[4] LOZANO M,HEDDLE N,WILLIAMSON L M,et al.Practices associated with ABO-incompatible platelet transfusions:a BEST Collaborative international survey[J].Transfusion,2010,50(8):1743-1748.
[5] DUNBAR N M,ORNSTEIN D L,DUMONT L J.ABO incompatible platelets:risks versus benefit[J].Curr Opin Hematol,2012,19(6):475-479.
[6] GUARENTE J,HARACH M,GOULD J,et al.Dilution is not the solution:acute hemolytic transfusion reaction after ABO-incompatible pooled platelet transfusion[J].Immunohematology,2019,35(3):91-94.
[7] YıLDıZ A,DOĞAN M,YALVAÇ M,et al.Platelet inventory and using out-of-group platelet suspension:a cost-effective strategy for a blood transfusion service[J].Hematol Oncol Stem Cell Ther,2023,16(4):337-341.
[8] PANDEY P,KUMARI S,MANDAL S,et al.A prospective observational study to compare transfusion outcomes in ABO identical versus ABO non-identical single donor platelet concentrates:an experience from a tertiary healthcare center in India[J].Transfus Clin Biol,2022,29(3):213-218.
[9] MALVIK N,LEON J,SCHLUETER A J,et al.ABO-incompatible platelets are associated with increased transfusion reaction rates[J].Transfusion,2020,60(2):285-293.
[10] PAVENSKI K,WARKENTIN T E,SHEN H,et al.Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients:an observational study[J].Transfusion,2010,50(7):1552-1560.
[11] DAS N,PRAKASH S,SAHU A,et al.Impact of dose and storage duration of platelet concentrates on platelet recovery between ABO identical and ABO non-identical random donor platelet transfusions in hemato-oncology patients[J].Hematol Transfus Cell Ther,2023:S2531-S1379(23)00038-X.
[12] 中国医师协会输血科医师分会,中华医学会临床输血学分会.特殊情况紧急抢救输血推荐方案[J].中国输血杂志,2014,27(1):1-3.
[13] 傅启华,王静.紧急抢救时ABO血型不相同血小板输注专家共识[J].中国输血杂志,2017,30(7):666-667.
[14] ZHU H J,MA Q Q,LI R S,et al.Blood group-related antigen Ley on human platelets and its involvement in platelet aggregation via a possible interaction with CD61[J].Transfusion,2020,60(9):2130-2138.
[15] SANT' ANNA GOMES B M,ESTALOTE A C,PALATNIK M,et al.Prevalence,serologic and genetic studies of high expressers of the blood group A antigen on platelets[J].Transfus Med,2010,20(5):303-314.
[16] 叶星晨. ABO血型非同型血小板输注[J].国际输血及血液学杂志,2015,38(2):182-184.
[17] DELELYS M E,OCHOA G,CSERTI-GAZDEWICH C M,et al.Relationship between ABO genotype and A antigen expression on platelets[J].Transfusion,2013,53(8):1763-1771.
[18] XU X G,XU F,YING Y L,et al.ABO antigen levels on platelets of normal and variant ABO blood group individuals[J].Platelets,2019,30(7):854-860.
[19] 凌霞,俞广舒,许先国.献血者血小板表面ABO血型抗原表达强度分析[J].中国输血杂志,2021,34(10):1069-1072.
[20] 曹开群,缪洪.血小板供应模式的应用价值探讨[J].健康必读,2018(35):212-214.
[21] 陆坷,李军.重庆主城区单采血小板供应现状及对策研究[J].国际检验医学杂志,2019,40(12):1515-1517.
[22] 梁明月,骆宏,黄伯泉,等.“取消互相献血” 政策对血小板供应的影响[J].当代医学,2020,26(22):20-22.
[23] 丁淑荣,张世翠.烟台地区2012年血液偏型紧张原因分析及对策[J].临床输血与检验,2014,16(1):89-90.
[24] 丁淑荣,张世翠.烟台地区2012年血液偏型紧张原因分析及对策[J].临床输血与检验,2014,16(1):89-90.
[25] 黄梅,郭晓明,文秀琼.2004—2008年绵阳市血液采供情况分析与对策[J].临床输血与检验,2010,12(2):159-161.
[26] MALVIK N,LEON J,SCHLUETER A J,et al.ABO-incompatible platelets are associated with increased transfusion reaction rates[J].Transfusion,2020,60(2):285-293.
[27] ZIELINSKI M D,SCHRAGER J J,JOHNSON P,et al.Multicenter comparison of emergency release group A versus AB plasma in blunt-injured trauma patients[J].Clin Transl Sci,2015,8(1):43-47.
[28] DUNBAR N M,YAZER M H,BIOMEDICAL EXCELLENCE FOR SAFER TRANSFUSION COLLABORATIVE AND THE STAT STUDY INVESTIGATORS.Safety of the use of group A plasma in trauma:the STAT study[J].Transfusion,2017,57(8):1879-1884.
[29] YAZER M H,SEHEULT J,KLEINMAN S,et al.Who’s afraid of incompatible plasma? A balanced approach to the safe transfusion of blood products containing ABO-incompatible plasma[J].Transfusion,2018,58(2):532-538.
[30] ZIELINSKI M D,JOHNSON P M,JENKINS D,et al.Emergency use of prethawed Group A plasma in trauma patients[J].J Trauma Acute Care Surg,2013,74(1):69-74;discussion 74-75.
[31] CHHIBBER V,GREENE M,VAUTHRIN M,et al.Is group A thawed plasma suitable as the first option for emergency release transfusion? (CME)[J].Transfusion,2014,54(7):1751-1755;quiz 1750.
[32] YAZER M,EDER A F,LAND K J.How we manage AB plasma inventory in the blood center and transfusion service[J].Transfusion,2013,53(8):1627-1633.
[33] NOVAK D J,BAI Y,COOKE R K,et al.Making thawed universal donor plasma available rapidly for massively bleeding trauma patients:experience from the Pragmatic,Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial[J].Transfusion,2015,55(6):1331-1339.
[34] KAPLAN A,SEVCIK J,KISS J E.Low titer A plasma in three AB patients for therapeutic plasma exchange[J].J Clin Apher,2019,34(1):7-12.
[35] DANIEL-JOHNSON J,LEITMAN S,KLEIN H,et al.Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions[J].Transfusion,2009,49(9):1845-1849.
[36] INABA S.Advancement in the preparation of red cell concentrates and platelet concentrates[J].Masui,2011,60(1):23-30.
[37] ROMPHRUK A V,CHEUNTA S,PAKOATE L,et al.Preparation of single donor platelet with low antibody titers for all patients[J].Transfus Apher Sci,2012,46(2):125-128.
[38] MATHUR A,SWAMY N,THAPA S,et al.Adding to platelet safety and life:platelet additive solutions[J].Asian J Transfus Sci,2018,12(2):136-140.
[39] BOJANIĆ I,LUKIĆ M,PLENKOVIĆ F,et al.Changes in the incidence of transfusion reactions in hematological patients over the past 30 years[J].Transfusion,2022,62(3):600-611.
[40] ADZAHAR S,HASSAN M N,ZULKAFLI Z,et al.Platelet additive solutions as an alternative storage medium of apheresis platelets to reduce ABO antibody titer for ABO-incompatibility platelet transfusion[J].Cureus,2023,15(8):e44012.
[41] REFAAI M A,FIALKOW L B,HEAL J M,et al.An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients[J].Vox Sang,2011,101(1):55-60.
[42] ESTCOURT L J,STANWORTH S,DOREE C,et al.Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation[J].Cochrane Database Syst Rev,2014(3):CD010984.
[43] TRIULZI D J,ASSMANN S F,STRAUSS R G,et al.The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia[J].Blood,2012,119(23):5553-5562.
[44] FONTAINE M J,WEBSTER J,GOMEZ S,et al.How do I implement an automated screen for high-titer ABO antibody as an inventory management tool for ABO plasma-incompatible platelets?[J].Transfusion,2015,55(12):2783-2789.
[45] 宋奎,许晓军,郭子文,等.造血干细胞移植患者血小板输注的疗效及影响因素[J].广东医学,2014,35(21):3393-3395.
[46] PARKHIDEH S,CHEGENI R,MEHDIZADEH M,et al.Effects of ABO incompatibility on the outcome of allogeneic hematopoietic stem cell transplantation[J].Transfus Apher Sci,2020,59(2):102696.
[47] STØY S,PATEL V C,STURGEON J P,et al.Platelet-leucocyte aggregation is augmented in cirrhosis and further increased by platelet transfusion[J].Aliment Pharmacol Ther,2018,47(10):1375-1386.
[48] 阳雪新,苑召虎,陈小洁,等.循环免疫复合物对血液病患者血小板输注疗效的影响[J].中国输血杂志,2022,35(4):404-408.
[49] 蔡晓红,雷航,王学锋. 2017年英国血液学标准委员会《血小板输注指南》和要点解读[J]. 诊断学理论与实践,2017,16(3):264-269.
[50] NEW H V,BERRYMAN J,BOLTON-MAGGS P H B,et al. Guidelines on transfusion for fetuses,neonates and older children[J]. Br J Haematol,2016,175(5):784-828.
[51] KAUFMAN R M,DJULBEGOVIC B,GERNSHEIMER T,et al.Platelet transfusion:a clinical practice guideline from the AABB[J]. Ann Intern Med,2015,162(3):205-213.
[52] 阳雪新,苑召虎,钟明璐,等.不同血液病患者血小板输注无效影响因素分析[J].岭南急诊医学杂志,2020,25(3):266-267.
[53] 郭芳,张琰,王改峰.重组人血小板生成素治疗免疫性血小板减少症的疗效及安全性观察[J].中国民康医学,2017,29(12):36-38.
[54] SLICHTER S J.Evidence-based platelet transfusion guidelines[J].Hematology Am Soc Hematol Educ Program,2007:172-178.
[55] JOSEPHSON C D,CASTILLEJO M I,GRIMA K,et al.ABO-mismatched platelet transfusions:strategies to mitigate patient exposure to naturally occurring hemolytic antibodies[J].Transfus Apher Sci,2010,42(1):83-88.
[56] PERSEGHIN P.High concentration plasma-reduced plateletapheresis concentrates[J].Transfus Apher Sci,2011,44(3):273-276.
[57] REFAAI M A,CARTER J,HENRICHS K F,et al.Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and-B[J].Transfusion,2013,53(2):382-393.

ABO非同型血小板输注的现状及建议^*

The Current Situation and Suggestions of ABO-mismatched Platelet Transfusions

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	阳雪新, 袁咏梅, 吴兆勇, 苑召虎, 刘珍, 童欣欣, 陈小卫, 魏亚明. ABO次侧不相合血小板输注的有效性和安全性初步研究^*[J]. 临床输血与检验, 2024, 26(1): 42-48.
[2]	杨牧云, 邓红英, 张杰, 戴万案. 恩施土家族苗族地区患者ABO正反定型不符原因及分子生物学分析[J]. 临床输血与检验, 2023, 25(6): 773-777.
[3]	徐晶, 杜忻, 陈佳, 余真强, 徐晓琴. 1例B/O嵌合血型献血者的测序结果分析及临床输血策略[J]. 临床输血与检验, 2023, 25(6): 845-847.
[4]	尤来委, 程勇, 郭建荣. ABO血型对癌症患者静脉血栓栓塞症影响的研究进展^*[J]. 临床输血与检验, 2023, 25(6): 857-861.
[5]	异基因造血干细胞移植临床输血专家共识起草专家组. 异基因造血干细胞移植临床输血专家共识[J]. 临床输血与检验, 2023, 25(5): 586-593.
[6]	刘铮, 孙亚敏, 邵树军, 康轶青, 王子清, 李建斌. 血小板输注无效患者的HLA-I类抗体特性分析^*[J]. 临床输血与检验, 2023, 25(5): 631-635.
[7]	卓海龙, 邵春燕, 骆群. 体外模拟A型/O型不同比例混合红细胞对血型抗原鉴定的影响^*[J]. 临床输血与检验, 2023, 25(4): 475-479.
[8]	赵彬, 陶千山, 沈元元, 董毅. R-CHOP方案治疗双表达弥漫大B细胞淋巴瘤有效性真实世界研究^*[J]. 临床输血与检验, 2023, 25(4): 533-538.
[9]	赵立哲, 李剑平, 李晓丰. 肠道菌群与人类ABO血型^*[J]. 临床输血与检验, 2023, 25(3): 297-301.
[10]	向倩, 任诗慧, 李晓明. 伊沙佐米治疗多发性骨髓瘤的疗效性与安全性的Meta分析^*[J]. 临床输血与检验, 2023, 25(2): 243-249.
[11]	谢惠益, 周载鑫, 杨玥, 王星怡, 李津杞, 牟显尧, 顾海慧, 钱宝华. 抗-M抗体影响血型鉴定及对临床输血的影响^*[J]. 临床输血与检验, 2022, 24(6): 716-720.
[12]	任倩, 李春苗, 刘兴莉. ABO变异型B311亚型的鉴定及家系分析^*[J]. 临床输血与检验, 2022, 24(6): 730-735.
[13]	姚丹, 丁虹娟, 余韦, 高明明, 俞兆儿, 贾瑞喆. 严重产后出血患者血小板输注的多变量预测模型^*[J]. 临床输血与检验, 2022, 24(6): 743-748.
[14]	李小薇, 李慧敏, 宁义平, 白晓莹, 李翠莹. B等位基因新突变导致B抗原弱表达1例^*[J]. 临床输血与检验, 2022, 24(5): 643-646.
[15]	中国输血协会人类组织抗原专业委员会, 中国输血协会免疫血液学专业委员会. 免疫性血小板输注无效的判定及临床实践专家共识^*[J]. 临床输血与检验, 2022, 24(3): 273-278.